Back to Nuveen, LLC Nuveen, LLC

SNDXSNDX
6 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in SYNDAX PHARMACEUTICALS INC

Nuveen, LLC holds 1.4M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $29.8M as of 2026-Q2. The position was decreased (-8.7% shares). SNDX represents 0.0% of Nuveen, LLC's portfolio.

Current Value

$29.8M

Current Shares

1.4M

Total Value Change

+$27.1M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.4M
-8.7%
$29.8M0.0%$21.86
0
2026-Q1
Increased
1.5M
+0.8%
$34.9M0.0%$21.40
29
2025-Q4
Increased
1.5M
+0.5%
$31.2M0.0%$20.74
29
2025-Q3
Increased
1.5M
+454.7%
$22.7M0.0%$15.56
46
2025-Q2
Increased
266,043
+18.7%
$2.5M0.0%$9.04
31
2025-Q1
New
224,153
-
$2.8M0.0%$13.18
36

Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used